Markets

Insider Trading

Hedge Funds

Retirement

Opinion

11 Low Price High Volume Stocks to Buy According to Analysts

In this article, we will take a look at the 11 Low Price High Volume Stocks to Buy According to Analysts.

Cheap or low-priced stocks can be an attractive option for investors seeking to make quick gains in the stock market. High-volume stocks may indicate increased investor sentiment towards the sector or a particular stock. However, investing in low-priced stocks can be risky, especially considering the current macroeconomic situation.

The market expects volatility with Powell drawing a fine line between curbing inflation and supporting the labor market. Wall Street largely expects Powell to signal an imminent easing in monetary policy; however, the concerns regarding Trump’s tariffs could provoke price pressures. This may force him to tread carefully.

Minutes from the Fed’s July 2025 meeting showed that central bankers expressed concerns regarding the state of the labor market and inflation. Most of the bankers agreed that it was too soon to lower interest rates.

“Participants generally pointed to risks to both sides of the Committee’s dual mandate, emphasizing upside risk to inflation and downside risk to employment,” the minutes noted.

The majority of participants saw the upside risk to inflation as the greater of these two risks. While a few viewed downside risk to employment as the more salient risk.

“There is a market tightrope here from a macroeconomic perspective between the inflation data and what’s happening in the employment market. And now you combine that with the political tightrope that’s not usually there that he has to navigate. It makes for an incredibly difficult, tricky situation,” said Tony Rodriguez, head of fixed income strategy at Nuveen.

With these market trends in mind, let’s turn to the 11 Low Price High Volume Stocks to Buy According to Analysts.

Our Methodology

To compile the list of 11 low price high volume stocks to buy according to analysts, we shortlisted the stocks from Finviz screener with the highest trading volume and stock price below $20 per share. We then ranked these best low price high volume stocks in ascending order of upside potential. We took the data for the upside potential from CNN. We also mentioned the number of hedge funds holding stakes in these stocks, and the data for hedge funds is taken from Insider Monkey’s Hedge Fund database, updated as of Q2 2025.

Note: The data was recorded on August 22.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

11 Low Price High Volume Stocks to Buy According to Analysts

11. Ondas Holdings Inc. (NASDAQ:ONDS)

Trading Volume: 65.69 Million

Price: $4.49

Analyst Upside: 11.36%

Number of Hedge Fund Holders: 9

Ondas Holdings Inc. (NASDAQ:ONDS) is one of the best low price high volume stocks to buy according to analysts. On August 21, Ondas Holdings Inc. (NASDAQ:ONDS) reported that its subsidiary received a $2.7 million purchase order from a leading defense customer for the Iron Drone Raider System.

Ondas’ subsidiary, Airobotics Ltd., received the purchase order for multiple units of the company’s autonomous counter-UAS platform. The continued expansion of Ondas’ Iron Drone System reflects the company’s execution and demand in global defense and homeland security markets.

“Iron Drone is demonstrating its effectiveness in real-world operations, where autonomous protection from aerial threats is essential to safeguard strategic facilities, mission-critical assets, and populations. We believe this trust further solidifies our role as a leading provider of advanced autonomous defense solutions,” said Eric Brock, Chairman and CEO of Ondas Holdings.

This order indicates recurring demand and validates the operational efficiency of the Iron Drone system, especially as a key element within layered defense structures. There is a growing concept of an interception and mitigation layer, which shows the significance of the Iron Drone system in such defense architectures.

Ondas Holdings Inc. (NASDAQ:ONDS) offers private wireless, drone, and automated data solutions. The company operates through two segments: Ondas Networks and Ondas Autonomous Systems.

10. B2Gold Corp. (NYSE:BTG)

Trading Volume: 34.12 Million

Price: $3.98

Analyst Upside: 19.65%

Number of Hedge Fund Holders: 27

B2Gold Corp. (NYSE:BTG) is one of the best low price high volume stocks to buy according to analysts. On August 20, B2Gold Corp. (NYSE:BTG) completed the purchase of 1.17 million common shares of Founders Metals Inc.

B2Gold Corp. (NYSE:BTG) increased its stake in Founders Metals by fulfilling the obligations under the Shareholder Agreement. The company completed the purchase of shares in the open market to carry out its agreement.

“B2Gold’s decision to increase its position demonstrates strong confidence in Founders and the Antino Gold Project. Their continued investment reinforces our shared belief in Antino as a Tier 1 discovery, and we’re pleased to have their ongoing support as we work to unlock the project’s full potential and realize value for shareholders,” Colin Padget, President and CEO of Founders Metals.

By implementing the agreement, B2Gold has preserved its right to participate in future financings up to a maximum of 9.9% ownership. The recent purchase has increased B2Gold’s total stake in Founders Metals to approximately 6%.

B2Gold Corp. (NYSE:BTG) is a gold mining company and operates the Fekola Mine, the Masbate Mine, the Otjikoto Mine, and the Gramalote gold project.

9. Snap Inc. (NYSE:SNAP)

Trading Volume: 62.02 Million

Price: $7.20

Analyst Upside: 25%

Number of Hedge Fund Holders: 35

Snap Inc. (NYSE:SNAP) is one of the best low price high volume stocks to buy according to analysts. On August 6, BofA lowered the price target on Snap Inc. (NYSE:SNAP) from $10 to $9.50, keeping its Neutral rating on the stock.

Justin Post from BofA downgraded the price target on SNAP following the Q2 FY2025 results. Post slightly adjusted the price target after the company missed both revenue and EBITDA estimates. The company posted revenue of $1.34 billion, missing consensus by $830,660 and up 9% from a year ago.

Post retains its neutral stance on SNAP following a Q3 revenue outlook that underwhelms expectations. The company expects its Q3 FY2025 revenue to be between $1.47 billion and $1.51 billion. Snap Inc. continues to improve its subscription base, with 932 million monthly active users in Q2, up by 7% from a year ago. Snapchat+ subscriptions reached 16 million, contributing notably to other revenue with a significant 64% year-over-year growth. The company continues to innovate with new products such as Lens+ and plans to launch its first stand-alone AR glasses in 2026.

Snap Inc. (NYSE:SNAP) is a technology company that operates one of the top social media platforms, Snapchat.

8. Amcor Plc (NYSE:AMCR)

Trading Volume: 20.39 Million

Price: $7.20

Analyst Upside: 25%

Number of Hedge Fund Holders: 47

Amcor Plc (NYSE:AMCR) is one of the best low price high volume stocks to buy according to analysts. On August 18, Amcor Plc (NYSE:AMCR) reported that it is expanding its healthcare packaging network in Costa Rica.

Amcor’s expansion of its healthcare packaging network in Costa Rica includes a new warehouse and distribution facility. Amcor’s facility will provide optimized supply chain efficiency for trays, die-cut lids, forming films, bags, and labels. The new warehouse and distribution center will now have an efficient supply chain, driven by speed of service and simplified customs management.

“Amcor continues to invest in operational solutions to solve our customers’ biggest challenges. Costa Rica is home to several of the world’s top MedTech OEMs, underscoring its role as a premier destination for medical technology investment and innovation,” said Art Castro, Vice President at Amcor.

Amcor will offer its best-in-class quality management to deliver fast access to a comprehensive product portfolio and improve the supply chain for customers.

Amcor Plc (NYSE:AMCR) is a delivery packaging firm and is engaged in packaging solutions for consumers and healthcare products. The company develops sustainable packaging in flexible and rigid formats across multiple materials.

7. Riot Platforms, Inc. (NASDAQ:RIOT)

Trading Volume: 52.24 Million

Price: $13.22

Analyst Upside: 34.27%

Number of Hedge Fund Holders: 48

Riot Platforms, Inc. (NASDAQ:RIOT) is one of the best low price high volume stocks to buy according to analysts. On August 6, Cantor Fitzgerald lowered the price target on Riot Platforms, Inc. (NASDAQ:RIOT) from $25 to $24, maintaining its Overweight rating on the stock.

Brett Knoblauch from Cantor Fitzgerald made a slight price adjustment following the company’s July production report, with Riot mining 484 Bitcoins during the month. The company’s Bitcoin mining production increased from 449 in June 2025. This was driven by significant participation in demand response programs, which generated approximately $13.9 million in power credits for July, up from $5.6 million in June and $3.7% million year-over-year.

Knoblauch remains positive on Riot Platforms as the company continues to increase its net Bitcoin sales proceeds. For July 2025, the company achieved $54.8 million in net BTC sales proceeds, a notable 31.4% increase from June. Moreover, the company plans to expand its hash rate to 38.4 EH/s by Q3 2025 and reach 45 EH/s by Q1 2026, which was recorded at 35.5 EH/s as of July’s end.

Riot Platforms, Inc. (NASDAQ:RIOT) is a Bitcoin mining company and is involved in comprehensive and critical infrastructure for institutional-scale Bitcoin mining facilities.

6. D-Wave Quantum Inc. (NYSE:QBTS)

Trading Volume: 29.67 Million

Price: $15.54

Analyst Upside: 35.14%

Number of Hedge Fund Holders: 24

D-Wave Quantum Inc. (NYSE:QBTS) is one of the best low price high volume stocks to buy according to analysts. On August 13, D-Wave Quantum Inc. (NYSE:QBTS) announced the launch of advanced cryogenic packaging to scale quantum process development.

D-Wave Quantum is working on a strategic initiative focused on advanced cryogenic packaging to accelerate the development of its gate-model and annealing quantum processors. This program is backed by D-Wave’s superconducting packaging expertise and focuses on enhancing multichip capabilities. It will also expand the manufacturing process to support larger and more powerful quantum systems.

D-Wave Quantum is leveraging superconducting bump-bond technology developed at NASA’s Jet Propulsion Laboratory. The company has also exhibited end-to-end superconducting interconnects between chips. D-Wave sees this as a key step in scaling its annealing and fluxonium-based gate-model structures. The company expects this project to advance its product roadmap to 100,000 qubits and further expand its leadership in quantum systems technology.

D-Wave Quantum Inc. (NYSE:QBTS) is a quantum computing company that develops and delivers quantum computing systems, software, and services.

6. PG&E Corporation (NYSE:PCG)

Trading Volume: 21.65 Million

Price: $15.19

Analyst Upside: 38.27%

Number of Hedge Fund Holders: 77

PG&E Corporation (NYSE:PCG) is one of the best low price high volume stocks to buy according to analysts. On August 11, PG&E Corporation (NYSE:PCG) announced one of the most advanced vehicle-to-grid (V2G) electric school bus fleets.

PG&E Corporation is launching one of California’s most advanced V2G electric school buses in collaboration with Fremont Unified School District and The Mobility House. This is a major milestone in clean transportation, grid resilience, and student health.

The Fremont Unified School District is now equipped with 14 electric school buses, including four Thomas Built and 10 Blue Bird buses. The company has also installed 22 electric vehicle chargers, in addition to 14 previously installed low-power chargers and six high-power bidirectional V2G DC fast charges. This infrastructure will minimize the use of combustion engine buses, with four new e-buses joining in 2025 and two more planned to enter service in 2026.

“This project is a shining example of how innovation creates a cleaner, smarter energy future. We’re proud to support Fremont USD and school districts across California as they convert to better, electrified student transportation,” said Mike Delaney, Vice President, Utility Partnership and Innovation, PG&E.

This marks the second school district participating in PG&E’s commercial fleet Vehicle-to-Everything (V2X) pilot. This program follows the company’s first successful deployment with Zum and Oakland Unified School District in 2024.

PG&E Corporation (NYSE:PCG) is a holding company and operates through its subsidiary, Pacific Gas and Electric Company. The utility firm is engaged in the sale and delivery of electricity and natural gas to customers in Northern and Central California.

4. Denison Mines Corp. (NYSE:DNN)

Trading Volume: 60.69 Million

Price: $2.08

Analyst Upside: 39.10%

Number of Hedge Fund Holders: 27

Denison Mines Corp. (NYSE:DNN) is one of the best low price high volume stocks to buy according to analysts. On August 18, Raymond James raised the price target on Denison Mines Corp. (NYSE:DNN) from C$3.80 to C$4, keeping its Outperform rating on the stock.

Brian MacArthur from Raymond James increased the price target on DNN, a second increase in a period of a month. MacArthur previously raised the price target from C$3.70 to C$3.80 on July 18, following the company’s discovery of additional high-grade mineralization. The recent upgrade follows Denison’s convertible senior unsecured notes completion, which raised around $345 million.

The offering also includes an upsized offering of $300 million and the full exercise of a $45 million option granted to initial purchasers. The net proceeds of around $333 million, after the deduction of expenses and commissions, will be used for the development of its uranium projects.

Denison Mines Corp. (NYSE:DNN) is engaged in the exploration and development of uranium properties in Canada. The company holds interests in the Athabasca Basin, Wheeler River, Midwest Project, McClean Lake, and Waterbury Lake.

3. MARA Holdings, Inc. (NASDAQ:MARA)

Trading Volume: 79.09 Million

Price: $16.29

Analyst Upside: 41.19%

Number of Hedge Fund Holders: 24

MARA Holdings, Inc. (NASDAQ:MARA) is one of the best low price high volume stocks to buy according to analysts. On August 11, MARA Holdings, Inc. (NASDAQ:MARA) announced the signing of an investment agreement with EDF Pulse Ventures to acquire their subsidiary, Exaion.

MARA Holdings and EDF Pulse Ventures have signed an agreement allowing MARA to acquire a majority 64% stake in Exaion. MARA has the option to increase its stake in Exaion up to 75% by 2027. Exaion develops and operates high-performance computing (HPC) data centers. The company also offers secure cloud and AI infrastructure in collaboration with leading players such as NVIDIA, Deloitte, and 2CRSI.

“Our partnership with Exaion would bring together two global leaders in data center development and digital energy. As data protection and energy efficiency become top priorities for both governments and enterprises, MARA and Exaion’s combined expertise would enable us to deliver secure and scalable cloud solutions built for the future of AI,” said Fred Thiel, MARA’s Chairman and CEO.

MARA will invest almost $168 million in cash upfront, with the opportunity to invest another $127 million to increase its stake to 75%. As part of the agreement, EDF will remain a client of Exaion and retain a minority interest. The transaction is expected to close around Q4 2025.

MARA Holdings, Inc. (NASDAQ:MARA) is a U.S.-based digital asset technology company that offers solutions to optimize data center operations. Its solutions include liquid immersion cooling and firmware for Bitcoin miners.

2. Precigen Inc. (NASDAQ:PGEN)

Trading Volume: 24.21 Million

Price: $4.18

Analyst Upside: 97.37%

Number of Hedge Fund Holders: 16

Precigen Inc. (NASDAQ:PGEN) is one of the best low price high volume stocks to buy according to analysts. On August 18, Citizens JMP raised the price target on Precigen Inc (NASDAQ:PGEN) from $6 to $8, keeping its Outperform rating on the stock.

Jason Butler from Citizens JMP increased the price target on PGEN following the approval of the company’s PAPZIMEOS for the treatment of respiratory papillomatosis. Butler remains bullish on the stock as the approval made PAPZIMEOS the first and only FDA-approved theory for adult RRP patients.

“With the landmark FDA approval of PAPZIMEOS and broad label, all adult RRP patients are now eligible for access to the first and only approved therapy that targets the root cause of the disease,” said Helen Sabzevari, President and CEO of Precigen.

The analyst pointed out the approval, mentioning the price, with a wholesale acquisition cost of $460,000 per patient. This is more than double compared to the company’s prior assumption of $200,000 per patient, Butler mentioned.

Precigen Inc. (NASDAQ:PGEN) is a clinical-stage biopharmaceutical company that develops gene and cell therapies. The company uses precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

1. IO Biotech, Inc. (NASDAQ:IOBT)

Trading Volume: 1.45 Million

Price: $1.74

Analyst Upside: 417.24%

Number of Hedge Fund Holders: 7

IO Biotech, Inc. (NASDAQ:IOBT) is one of the best low price high volume stocks to buy according to analysts. On August 15, H.C. Wainwright reiterated a Buy rating on IO Biotech, Inc. (NASDAQ:IOBT), keeping its price target at $14.

Emily Bodnar from H.C. Wainwright maintained the rating on IOBT based on the company’s recent development and future potential. The company’s pivotal phase 3 trial for the Cylembio therapy showed a clinically meaningful improvement in progression-free survival (PFS) for patients suffering from advanced melanoma. The analyst remains positive on the company’s development even though the trial narrowly missed its primary endpoint.

The company plans to submit a biologics license application to the U.S. FDA for Cylembio by the end of 2025. Moreover, IO Biotech’s pipeline includes promising phase 2 trials for other cancer types, with data expected in the near future. Bodnar sees these factors as contributing to the positive outlook. The company’s innovative therapies have the potential to address unmet medical needs in oncology.

IO Biotech, Inc. (NASDAQ:IOBT) is a clinical-stage biopharmaceutical firm that develops immune-modulating therapeutic cancer treatments or vaccines based on the T-win technology platform.

While we acknowledge the potential of IOBT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IOBT and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.